Abstract
A commentary on outcomes with liquid biopsy to determine the epidermal growth factor receptor mutation status in poor performance status, biopsy-ineligible, advanced non-small cell lung cancer patients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have